Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AANAT mRNA | affects expression | 16483693
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AANAT mRNA | affects cotreatment|decreases expression | 20360939
|
C059041 |
calyculin A |
calyculin A results in decreased activity of AANAT protein | decreases activity | 11442772
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AANAT mRNA | affects cotreatment|decreases expression | 20360939
|
D012701 |
Serotonin |
AANAT protein binds to and results in increased acylation of Serotonin | affects binding|increases acylation | 15644438
|
D008094 |
Lithium |
Lithium inhibits the reaction [Methamphetamine results in decreased expression of AANAT mRNA] | decreases expression|decreases reaction | 19149911
|
D008694 |
Methamphetamine |
Lithium inhibits the reaction [Methamphetamine results in decreased expression of AANAT mRNA] | decreases expression|decreases reaction | 19149911
|
D008694 |
Methamphetamine |
Methamphetamine results in decreased expression of AANAT mRNA | decreases expression | 19149911
|
D008694 |
Methamphetamine |
Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of AANAT mRNA] | decreases expression|decreases reaction | 19149911
|
D019319 |
Okadaic Acid |
Okadaic Acid results in decreased activity of AANAT protein | decreases activity | 11442772
|
D019319 |
Okadaic Acid |
Okadaic Acid results in decreased expression of AANAT mRNA | decreases expression | 11442772
|
D014501 |
Uranium |
Uranium affects the expression of AANAT mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of AANAT mRNA | affects expression | 15672453
|
D014635 |
Valproic Acid |
Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of AANAT mRNA] | decreases expression|decreases reaction | 19149911
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.68 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.07 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.93 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.09 | 18056438 19061943 17162532 19052882 17620307 16434500 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.49 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.45 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.68 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
2.61 | 18062943 8570775 18361446 15132762 17157402 18405062 19221690 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.61 | 17507914 18985861 17157402 18558336 17688650 15238991 18940202 18316065 16609825 18396377 18775368 19460635 20603192 19232924 18177632 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
7.83 | 20046352 19153942 20338123 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
7.83 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.49 | 8888407 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.67 | 8112388 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.22 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.86 | 18971187 20514400 11831363 18506893 16779866 19519916 21159647 16288022 20512989 20935162 19822196 17428255 19418558 10672840 20084675 18785209 10737359 19335982 18665156 16807293 16681979 3581430 18691550 17761372 18056438 17173139 20524982 18393292 20007298 18210153 20432363 3084413 18788625 19701751 19383236 19394651 16540662 17978847 16328049 19539802 16935385 19171122 16569478 19052882 19107877 17138121 16698587 18494052 16830150 20214788 16878318 18978308 17055752 20727157 20101231 19919837 16502159 17162532 19208518 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.95 | 21159647 7505956 2727394 17174075 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
6.59 | 21254450 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
6.59 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.81 | 19052882 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.91 | 17157402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 16575769 17688650 |
MESH:D007644 |
Darier Disease |
|
Lithium |
6.10 | 20338123 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.92 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.22 | 20387270 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
4.93 | 8112388 11488427 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.08 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.08 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.20 | 1851702 |
MESH:D004487 |
Edema |
|
Serotonin |
4.61 | 18841975 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.33 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.13 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.00 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.71 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.47 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.26 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.35 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.35 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.10 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.29 | 8888407 18558336 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
4.71 | 17312396 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
4.28 | 19638421 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.06 | 17688650 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
5.70 | 17658665 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.44 | 18785209 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.72 | 10783313 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.62 | 15369732 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.08 | 16766008 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.89 | 18665156 18522880 20032147 18407596 19638242 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.13 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.28 | 19254457 19256749 19255062 18644402 19996281 18754104 18648771 19833225 21167192 19690152 19294768 19426721 15885732 19812893 20583210 20137499 15175105 12112319 18977376 19638242 20101389 20405173 19090486 10737359 19073162 21047994 2422723 21278145 19642983 19499222 21071580 12771043 19551842 20452335 20118626 9163691 18978307 20492335 19850985 20434301 20501860 2862719 16942905 19427195 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.71 | 18079962 18253720 18093689 2563599 3124819 9362446 18544905 17174075 18775883 17854601 17942915 19126423 19009564 19004024 18282651 19519916 16842330 18164116 18308698 19539802 16267830 21159647 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.48 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 20970405 21163286 6695378 20512841 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.29 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.17 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
3.97 | 16288908 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.61 | 9029167 3581430 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.21 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.46 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.46 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.68 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.02 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.76 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.32 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Lithium |
6.79 | 19660546 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.79 | 11738929 14763951 15475178 16876388 17978042 11044598 3137016 1511512 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
4.29 | 12628509 |
MESH:D012893 |
Sleep Disorders |
marker/mechanism |
|
| |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
13.40 | 19951488 19430551 19570321 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
13.40 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.09 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.45 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.71 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.82 | 8888407 |